Table 1.

Selected prostate cancer risk factors by use of cholesterol-lowering drugs, Cancer Prevention Study II Nutrition Cohort

Never use (n = 41,872), %Former use (n = 2,057), %Current use, <5 y (n = 6,653), %Current use, ≥5 y (n = 4,872), %
Age (y)
    50-594.33.13.42.4
    60-6951.644.656.351.4
    70-7940.448.938.643.6
    ≥803.73.51.72.5
Race
    White97.896.898.197.9
    Black0.91.70.60.8
    Other or unknown1.21.51.41.3
Education
    <High school7.28.66.86.1
    High school graduate18.218.717.917.7
    Some college25.127.526.225.2
    College graduate22.321.022.824.4
    Graduate school26.623.725.725.9
    Unknown0.60.40.60.7
BMI
    <2534.533.930.630.4
    25-<3043.444.746.548.2
    30-<3511.611.312.312.0
    ≥352.52.12.42.5
    Unknown7.98.08.26.9
Family history of prostate cancer17.014.516.015.2
NSAID use (pills/mo)
    None34.325.317.817.8
    1-1423.822.922.522.6
    15-298.58.66.77.8
    30-5914.618.324.624.8
    ≥607.58.18.07.9
    User, unknown quantity11.216.820.419.1
History of PSA testing
    Never17.413.011.910.1
    Yes, test in last 2 y63.863.971.173.7
    Yes, test >2 y ago10.512.08.98.9
    Unknown8.311.18.07.3
Elevated cholesterol*26.485.089.395.5
Heart attack history12.534.849.149.5
Diabetes history9.313.513.413.4
  • NOTE: Percentages were adjusted to the age distribution of the entire study population.

  • * Ever had elevated cholesterol, as self-reported by participants.